The case of a 24-year-old woman with Pseudomonas aeruginosa and Proteus mirabilis chronic calcaneal osteomyelitis is presented. Extensive debridement of the necrotic bone and application of tobramycin-loaded polymethylmethacrylate beads was performed and ciprofloxacin was given post-operatively. Three months later, laboratory tests, including complete blood cell count, erythrocyte sedimentation rate and C-reactive protein, were normal. At this time, extensive surgical debridement and filling of the osseous defect with autologous iliac cancellous bone graft and tobramycin-impregnated calcium sulphate pellets and paste were performed. Oral ciprofloxacin was administered for 3 months after surgery. At the latest follow-up, 2 years later, the patient had full weight-bearing function; there was no recurrence of the infection, and complete incorporation of the autologous bone and calcium sulphate graft with the host bone was observed. This case demonstrates that two-stage surgical treatment with extensive debridement and tobramycin-impregnated calcium sulphate was effective in treating chronic calcaneal osteomyelitis.
CrandallRCWagnerFW: Partial and total calcanectomy: A review of thirty-one consecutive cases over a ten-year period. J Bone Joint Surg Am1981; 63: 152–155.
2.
IsenbergJSCostiganWMThordarsonDB: Subtotal calcanectomy for osteomyelitis of the os calcis: A reasonable alternative to free tissue transfer. Ann Plast Surg1995; 35: 660–663.
3.
WollTSBealsRK: Partial calcanectomy for the treatment of osteomyelitis of the calcaneus. Foot Ankle1991; 12: 31–34.
4.
LevinLSNunleyJA: The management of soft-tissue problems associated with calcaneal fractures. Clin Orthop Relat Res1993; 290: 151–156.
5.
del PiñalFHerreroFCruzA: A technique to preserve the shape of the calcaneus after massive osteomyelitis. Br J Plast Surg1999; 52: 415–417.
6.
AttingerCCooperP: Soft tissue reconstruction for calcaneal fractures or osteomyelitis. Orthop Clin North Am2001; 32: 135–170.
CoskunfiratOKVelidedeogluHVSahinÜDemirZ: Reverse neurofasciocutaneous flaps for soft-tissue coverage of the lower leg. Ann Plast Surg1999; 43: 14–20.
9.
JengSFWeiFCKuoYR: Salvage of the distal foot using distally based sural island flap. Ann Plast Surg1999; 43: 499–505.
10.
YilmazMKaratasOBarutçuA: The distally based superficial artery island flap: Clinical experience and modifications. Plast Reconstr Surg1998; 102: 2358–2367.
11.
YildirimSGiderogluKAkozT: The simple and effective choice for treatment of chronic calcaneal osteomyelitis: Neurocutaneous flaps. Plast Reconstr Surg2003; 111: 753–760.
BaravarianBMenendezMMWeinheimerDJLoweryCKosanovichRVidtL: Subtotal calcanectomy for the treatment of large heel ulceration and calcaneal osteomyelitis in the diabetic patient. J Foot Ankle Surg1999; 38: 194–202.
14.
BaumhauerJFFragaCJGouldJSJohnsonJE: Total calcanectomy for the treatment of chronic calcaneal osteomyelitis. Foot Ankle Int1998; 19: 849–855.
15.
MayJWGallicoGGLukashFN: Microvascular transfer of free tissue for closure of bone wounds of the distal lower extremity. N Engl J Med1982; 306: 253–257.
16.
AnthonyJPMathesSJAlpertBS: The muscle flap in the treatment of chronic lower extremity osteomyelitis: Results in patients over 5 years after treatment. Plast Reconstr Surg1991; 88: 311–318.
17.
GayleLBLineaweaverWCOlivaASikoPPAlpertBSBunckeGM: Treatment of chronic osteomyelitis of the lower extremities with debridement and microvascular muscle transfer. Clin Plast Surg1992; 19: 895–903.
18.
WeilandAJMooreJRDanielRK: The efficacy of free tissue transfer in the treatment of osteomyelitis. J Bone Joint Surg Am1984; 66: 181–193.
19.
RussellRCGrahamDRFellerAMZookEGMathurA: Experimental evaluation of the antibiotic carrying capacity of a muscle flap into a fibrotic cavity. Plast Reconstr Surg1988; 81: 162–170.
20.
MasemMGreenbergBMHoffmanCHooperDCMayJW: Comparative bacterial clearances of muscle and skin/subcutaneous tissues with and without dead bone: A laboratory study. Plast Reconstr Surg1990; 85: 773–781.
21.
FitzgeraldRH: Experimental osteomyelitis: Description of a canine model and the role of depot administration of antibiotics in the prevention and treatment of sepsis. J Bone Joint Surg Am1983; 65: 371–380.
22.
LaurencinCTGerhartTWitschgerPSatcherPDombARosenbergAE: Bioerodible polyanhydrides for antibiotic drug delivery: in vivo osteomyelitis treatment in a rat model system. J Orthop Res1993; 11: 256–262.
23.
SasmorMTMorainWDBalestreroLMCampBJ: Investigation of a biodegradable, implantable antibiotic delivery system on rate of wound infection. Ann Plast Surg1993; 30: 525–530.
24.
NelsonCMcLarenSGSkinnerRASmeltzerMSThomasJROlsenKM: The treatment of experimental osteomyelitis by surgical debridement and the implantation of calcium sulfate tobramycin pellets. J Orthop Res2002; 20: 643–647.
25.
PerryCRPearsonRL: Local antibiotic delivery in the treatment of bone and joint infection. Clin Orthop Relat Res1991; 263: 215–226.
26.
ZilchHLambirisE: The sustained release of cefotaxim from a fibrin-cefotaxim compound in treatment of osteitis. Pharmacokinetic study and clinical results. Arch Orthop Trauma Surg1986; 106: 36–41.
27.
DahnersLEFunderburkCH: Gentamicin-loaded plaster of Paris as a treatment of experimental osteomyelitis in rabbits. Clin Orthop Relat Res1987; 219: 278–282.
SalvatiEACallaghanJJBrauseBDKleinRFSmallRD: Reimplantation in infection. Elution of gentamicin from cement and beads. Clin Orthop Relat Res1986; 207: 83–93.
30.
KorkusuzFUchidaAShintoYArakiNInoueIOnoK: Experimental implant-related osteomyelitis treated by antibiotic calcium hydroxyapatite ceramic composites. J Bone Joint Surg Br1993; 75: 111–114.
31.
ShintoYUchidaAKorkusuzFArakiNOnoK: Calcium hydroxyapatite ceramic used as a delivery system for antibiotics. J Bone Joint Surg Br1992; 74: 600–604.
32.
YamashitaYUchidaAYamakawaTShintoYArakiNKatoK: Treatment of chronic osteomyelitis using calcium hydroxyapatite ceramic implants impregnated with antibiotic. Int Orthop1998; 22: 247–251.
33.
EckmanJBJrHenrySLManginoPDSeligsonD: Wound and serum levels of tobramycin with the prophylactic use of tobramycin-impregnated polymethylmethacrylate beads in compound fractures. Clin Orthop Relat Res1988; 237: 213–215.
34.
BeardmoreAABrooksDEWenkeJCThomasDB: Effectiveness of local antibiotic delivery with an osteoinductive and osteoconductive bone-graft substitute. J Bone Joint Surg Am2005; 87: 107–112.
35.
BaystonRMilnerRD: The sustained release of antimicrobial drugs from bone cement. An appraisal of laboratory investigations and their significance. J Bone Joint Surg Br1982; 64: 460–464.
36.
BowyerGWCumberlandN: Antibiotic release from impregnated pellets and beads. J Trauma1994; 36: 331–335.
37.
NelsonCLGriffinFMHarrisonBHCooperRE: In vitro elution characteristics of commercially and noncommercially prepared antibiotic PMMA beads. Clin Orthop Relat Res1992; 284: 303–309.
38.
NelsonCLHickmonSGHarrisonBH: Elution characteristics of gentamicin-PMMA beads after implantation in humans. Orthopedics1994; 17: 415–416.
39.
GitelisSBrebachGT: The treatment of chronic osteomyelitis with a biodegradable antibiotic-impregnated implant. J Orthop Surg (Hong Kong)2002; 10: 53–60.
40.
BeckerPLSmithRAWilliamsRSDutkowskyJP: Comparison of antibiotic release from polymethylmethacrylate beads and sponge collagen. J Orthop Res1994; 12: 737–741.
41.
NelsonCLHickmonSGSkinnerRA: Treatment of experimental osteomyelitis by surgical debridement and the implantation of bioerodable, polyanhydride-gentamicin beads. J Orthop Res1997; 15: 249–255.
42.
ArmstrongDGFindlowAHOyiboSOBoultonAJ: The use of absorbable antibiotic-impregnated calcium sulphate pellets in the management of diabetic foot infections. Diabet Med2001; 18: 942–943.
43.
DamienCJParsonsJR: Bone graft and bone graft substitutes: A review of current technology and applications. J Appl Biomater1991; 2: 187–208.
44.
SidquiMCollinPVitteCForestN: Osteoblast adherence and resorption activity of isolated osteoclasts on calcium sulphate hemihydrate. Biomaterials1995; 16: 1327–1332.
45.
TurnerTMUrbanRMGitelisSInfangerSBerzinsAHallDJ: Efficacy of calcium sulfate, a synthetic bone graft material, in healing a large canine medullary defect. 45th Annual Meeting, Orthopedic Research Society, Anaheim, California, USA, 1-4 February 1999. Abstract 522.
46.
GreenwaldASBodenSDGoldbergVMKhanYLaurencinCTRosierRN; American Academy of Orthopaedic Surgeons; The Committee on Biological Implants: Bone-graft substitutes: Facts, fictions, and applications. J Bone Joint Surg Am2001; 83: 98–103.
47.
KellyCMWilkinsRMGitelisSHartjenCWatsonJTKimPT: The use of a surgical grade calcium sulfate as a bone graft substitute: Results of a multicenter trial. Clin Orthop Relat Res2001; 382: 42–50.
48.
TurnerTMUrbanRMGitelisSKuoKNAnderssonGB: Radiographic and histologic assessment of calcium sulfate in experimental animal models and clinical use as a resorbable bone-graft substitute, a bone-graft expander, and a method for local antibiotic delivery. One institution's experience. J Bone Joint Surg Am2001; 83: 8–18.
49.
MoussetBBenoitMADelloyeCBouilletRGillardJ: Biodegradable implants for potential use in bone infection. An in vitro study of antibiotic-loaded calcium sulphate. Int Orthop1995; 19: 157–161.
50.
MackeyDVarletADebeaumontD: Antibiotic loaded plaster of Paris pellets: An in vitro study of a possible method of local antibiotic therapy in bone infection. Clin Orthop Relat Res1982; 167: 263–268.
51.
WichelhausTADingeldeinERauschmannMKlugeSDieterichRSchäferV: Elution characteristics of vancomycin, teicoplanin, gentamicin and clindamycin from calcium sulphate beads. J Antimicrob Chemother2001; 48: 117–119.
52.
McKeeMDWildLMSchemitschEHWaddellJP: The use of an antibiotic-impregnated, osteoconductive, bioabsorbable bone substitute in the treatment of infected long bone defects: Early results of a prospective trial. J Orthop Trauma2002; 16: 622–627.
